One-Compartment PK (IV)
ورودیهای بالینی بیمار
حداقل ۰.۰۱ — حداکثر ۱۰۰۰۰۰
حداقل ۰.۰۱ — حداکثر ۱۰۰۰
حداقل ۱ — حداکثر ۱۰۰۰ • واحد: L
حداقل ۰.۰۰۱ — حداکثر ۵ • واحد: /h
حداقل ۱ — حداکثر ۱۶۸ • واحد: h
حداقل ۰.۱ — حداکثر ۲۴ • واحد: h
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Computed0–0
The One-Compartment PK (IV) calculates calculating standardized physiological indices and stratifying general clinical risk. Key inputs include mode. Scores guide individualizing bedside clinical management, scheduling routine follow-up, and monitoring clinical progress. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
One-compartment pharmacokinetic dose individualization for intermittent IV dosing at steady state. Predict mode: Cmax_ss and Cmin_ss from dose, Vd, Ke, and interval (IV bolus or infusion). Dose-for-target mode: solves the dose needed to achieve a target trough (bolus). Standard steady-state equations.
Clinical Indication
The One-Compartment PK (IV) is indicated for bedside clinical practice to support One-compartment pharmacokinetic dose individualization for intermittent IV dosing at steady state. Predict mode: Cmax_ss and Cmin_ss from dose, Vd, Ke, and interval (IV bolus or infusion). Dose-for-target mode: solves the dose needed to achieve a target trough (bolus). Standard steady-state equations.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult ambulatory and hospitalized patient cohorts evaluated for systemic illness, physiologic risk, or diagnostic probability. Clinical application is indicated across General medical-surgical inpatient units, primary care clinics, and ambulatory outpatient facilities.
Limitations & Contraindications
Single-point score values can obscure rapid temporal clinical deterioration; serial clinical reassessment is essential.
Clinical Pearls & Action Plan
Calculated indices must be contextualized alongside complete clinical history, physical exam, and dynamic trajectory.
Bolus: Cmax_ss=(Dose/V)/(1-e^(-Ke*τ)); Cmin_ss=Cmax_ss*e^(-Ke*τ). Infusion: Cmax_ss=(R0/(Ke*V))*(1-e^(-Ke*tinf))/(1-e^(-Ke*τ))
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| mode | string | Yes | Mode |
| route | string | Yes | Route |
| dose | float | No | Dose per administration in mg (predict mode) |
| target_trough | float | No | Target trough in mg/L (dose_for_target mode, bolus only) |
| vd | float | Yes | Volume of distribution(L) |
| ke | float | Yes | Elimination rate constant(/h) |
| tau | float | Yes | Dosing interval(h) |
| tinf | float | No | Infusion duration in hours (infusion route)(h) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Computed | PK prediction |
Evidence-Based References (EBM)
- Standard one-compartment intermittent IV steady-state equations (e.g. Shargel & Yu, Applied Biopharmaceutics & Pharmacokinetics).